Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 110, Issue 14, Pages 5570-5575Publisher
NATL ACAD SCIENCES
DOI: 10.1073/pnas.1302935110
Keywords
-
Categories
Funding
- Australian National Health and Medical Research Council (NHMRC) Project Grant [AI1008854, APP567122]
- National Institutes of Health [AI170251]
- Australian Postgraduate Award
- NHMRC Senior Research Fellow
- NHMRC Senior Principal Research Fellow
- Australian Research Council Future Fellows
- NHMRC Australia Fellow
Ask authors/readers for more resources
A reverse-genetics approach has been used to probe the mechanism underlying immune escape for influenza A virus-specific CD8(+) T cells responding to the immunodominant (DNP366)-N-b epitope. Engineered viruses with a substitution at a critical residue (position 6, P6M) all evaded recognition by WT (DNP366)-N-b-specific CD8(+) T cells, but only the NPM6I and NPM6T mutants altered the topography of a key residue (His155) in the MHC class I binding site. Following infection with the engineered NPM6I and NPM6T influenza viruses, both mutations were associated with a substantial hole in the naive T-cell receptor repertoire, characterized by very limited T-cell receptor diversity and minimal primary responses to the NPM6I and NPM6T epitopes. Surprisingly, following respiratory challenge with a serologically distinct influenza virus carrying the same mutation, preemptive immunization against these escape variants led to the generation of secondary CD8(+) T-cell responses that were comparable in magnitude to those found for the WT NP epitope. Consequently, it might be possible to generate broadly protective T-cell immunity against commonly occurring virus escape mutants. If this is generally true for RNA viruses (like HIV, hepatitis C virus, and influenza) that show high mutation rates, priming against predicted mutants before an initial encounter could function to prevent the emergence of escape variants in infected hosts. That process could be a step toward preserving immune control of particularly persistent RNA viruses and may be worth considering for future vaccine strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available